| Goal | Aerobic capacity, fat oxidation, resting heart rate |
|---|---|
| Duration | 12 weeks, then maintain |
| Time cost | 3.5 h/week (3 × 45–70 min) |
| Money cost | £0 — optional heart-rate strap, ~£40 |
| Effort | Low intensity, high consistency |
| Measured by | Resting HR, HR at fixed pace, 12-min distance test |
| Stacks with | VO₂max Intervals 4×4, Progressive Resistance Minimum |
The claim, stated precisely
In previously untrained or moderately trained adults, accumulating 150–210 minutes per week of continuous exercise at an intensity where blood lactate stays near resting levels — roughly a pace you can hold a conversation at — produces measurable gains in aerobic capacity and reductions in resting heart rate within 8 to 12 weeks.
That is the whole claim. It does not say Zone 2 is superior to intervals, that it burns more fat overall, or that it extends lifespan on its own. Those are separate claims and they grade differently.
The protocol
Phase 1 — Find the ceiling
Weeks 1–2Three sessions per week, 30–40 minutes. Set the pace by the talk test: you can speak a full sentence without gasping, but you would not choose to. If you have a heart-rate strap, note the number this pace produces — that becomes your working ceiling.
Phase 2 — Accumulate
Weeks 3–10Extend sessions to 45–70 minutes, holding the same intensity. Add roughly 10% total weekly duration every second week. The intensity never rises; only the volume does. This is the part people abandon.
Phase 3 — Re-test
Weeks 11–12Repeat the baseline test under the same conditions — same time of day, same route, similar sleep. Compare heart rate at a fixed pace rather than perceived effort, which drifts.
What the evidence supports
Grade A here rests on a large and old literature: continuous moderate-intensity training improves VO₂max and submaximal heart rate across dozens of randomised trials, in multiple populations, with independent replication. This is not a contested finding.
- Direction: consistent across trials.
- Effect size: typically 10–20% VO₂max improvement in untrained adults over 8–12 weeks; much smaller in trained ones.
- Replication: extensive, independent, and not industry-funded.
- Adherence in trials: the weak point — dropout in long low-intensity arms runs high.
Where it stops
The popular version of this protocol claims far more than the trials do. Three places the evidence thins out:
- Mitochondrial claims. Biopsy studies are small and short. Directionally plausible; not Grade A.
- “Zone 2 specifically.” Most trials tested moderate continuous exercise, not a precisely-bounded lactate zone. The precision in the branding exceeds the precision in the data.
- Longevity. Fitness predicts mortality strongly in cohorts. That is an association, and this protocol does not inherit it as a proven causal outcome.
If you have a known cardiac condition, uncontrolled blood pressure, or you have been sedentary for years, get cleared by a clinician first. Chest pain, unusual breathlessness, or fainting during exercise means stop and seek medical attention — not push through.
Changelog
| 4 Aug 2026 | Reviewed. Grade held at A. Mitochondrial sub-claim split out and graded C separately. |
|---|---|
| 17 Jan 2026 | Time cost revised from 3 h to 3.5 h/week to reflect trial protocols rather than popular summaries. |
| 2 Sep 2025 | Entry created. |
